Citi Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Go back to Citi Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 255.36 -0.6 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $255.96 | 52 Week High | $109.10 | |||
| Open | $256.28 | 52 Week Low | $31.38 | |||
| Day High | $256.36 | P/E | N/A | |||
| Day Low | $248.12 | EPS | $-1.45 | |||
| Volume | 1,147,872 | |||||
